David has extensive experience in both the investment in and management of emerging technologies and operational experience within a broad range of businesses.
Over 30 years, David has gained deep experience in R&D, product development and commercialisation across biotech, medical device, IVD and data-driven solutions in all global markets.
As Managing Partner of BioScience Managers, David is responsible for driving the future growth of BioScience Managers in new and existing geographies, and to build on successes in digital health.
He adds value by proactively engaging with our current portfolio to deliver commercial success and returns for investors.
David is an accomplished global healthcare leader with experience across a broad range of life science and healthcaresectors. Over the last 30 years, he has held national, regional and global roles across the pharmaceutical, medical device and diagnostics sectors. David’s responsibilities have covered all functions from discovery research through to sales and marketing in most key geographies. He has valuable experience in start-up ventures, scale-ups, turnarounds and high-growth enterprises. He has held senior leadership roles in smaller businesses including Congenica (UK), Veridex (US) and Gene Shears (Australia), and larger global businesses including Johnson & Johnson and Danaher.
David has an MBA, Finance from Columbia Business School, USA, a Postgraduate Certificate in Pharmacology from UNSW, Australia, a PhD in Molecular Virology from John Innes Institute and a BSc in Biological Sciences from the University of East Anglia, UK.
Current board positions
Bioscience Managers UK Ltd. (UK)
Gene People (Trustee)
Previous board positions